Rankings
▼
Calendar
NUVB
Nuvation Bio Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$9M
EPS (Diluted)
$-0.05
Cash Flow
Operating Cash Flow
-$3,923
Free Cash Flow
-$3,923
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
$744,000
Stockholders' Equity
-$744,000
Cash & Equivalents
-$138,000
← FY 2019
All Quarters
Q2 2019 →
NUVB Q1 2019 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
